ArticleFrontiers in neurology2022

Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine-A Real-Life Study.

Magdalena Nowaczewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.